Check SBP's last 9 months' of announcemnets and then I think you will agree with me that the long awaited FDA approval appears to be imminent; looking at the last 5-6 days trading volumes and price appreciation.
I'm very happy with the current situation anyway, but the key announcement and the associated media coverage and recognition by institutional and overseas biotech investors that "SBP really does have something".
If you can find a more under-valued biotech stock, with the same incredible 'blue sky' potential, that SBP has, either in Oz,the States or EU markets, let me know.
SBP
solbec pharmaceuticals limited
